Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TXG compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name
TXG
10x Genomics, Inc.
Change
Mkt cap
Revenue
Revenue
A
Agilent Technologies, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TXG
10x Genomics, Inc.
vs
A
Agilent Technologies, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TXG: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TXG
4
BRKR
Bruker
customer
—
President and Fellows of Harvard University
unlisted
supplier
—
The Board of Trustees of the Leland Stanford Junior University
unlisted
supplier
—
Vizgen
unlisted
customer
Shared
0
No shared counterparties.
Only A
2
ALNY
Alnylam Pharmaceuticals
customer
WGS
GeneDx
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TXG, solid
A, dashed
TXG
10x Genomics, Inc.
Change
65.30
· pre 66.98
· delayed
Mkt cap
$8.5B
Revenue
$151M
Q2 FY26
Revenue
$643M
FY25
A
Agilent Technologies, Inc.
Change
175.74
· pre 175.99
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$48.5B
Revenue
$1.9B
Q3 FY26
Revenue
$6.9B
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
TXG
10x Genomics, Inc.
vs
A
Agilent Technologies, Inc.
65.30
pre 66.98
delayed
Price
175.74
pre 175.99
delayed
$8.5B
Mkt cap
$48.5B
Q2 FY26
$151M
Revenue
$1.9B
Q3 FY26
FY25
$643M
Revenue
$6.9B
FY25
Change
Change
TXG
65.30
vs
A
175.74
Pre-market
Nov 4 '26
delayed